A Single-centre, Open-label, Five-way Crossover Study in Healthy Female Participants to Assess the Pharmacokinetics of Nasally Administered Formulations of Teriparatide Compared to a Subcutaneous Injection.

Trial Profile

A Single-centre, Open-label, Five-way Crossover Study in Healthy Female Participants to Assess the Pharmacokinetics of Nasally Administered Formulations of Teriparatide Compared to a Subcutaneous Injection.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Teriparatide (Primary) ; Teriparatide (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Pharmacokinetics
  • Acronyms NINTTO
  • Most Recent Events

    • 21 Jun 2014 Accrual to date is 100% according to United Kingdom Clinical Research Network.
    • 15 Apr 2014 Status changed from not yet recruiting to recruiting, according to a Critical Pharmaceuticals media release.
    • 18 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top